Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Thu 13 May 2004, 17:01 GROUP RESULTS AND DIVIDEND DECLARATION
TIGER BRANDS LIMITED - GROUP RESULTS AND DIVIDEND DECLARATION                   
  Tiger Brands Limited                                                            
  (Registration number 1944/017881/06)                                            
  (Incorporated in the Republic of South Africa)                                  
  JSE Share code: TBS                                                             
  ISIN: ZAE 000023560                                                             
  GROUP RESULTS AND DIVIDEND DECLARATION                                          
  Highlights                                                                      
  *    Headline earnings per share +28%                                           
  *    Operating income from operating operations +38%                            
  *    Intention to unbundle Spar                                                 
  The unaudited results for the six months ended 31 March 2004 are set out herein.
  This report has been prepared using the same principles as contained in AC127 - 
  Interim Financial Reporting. The principles adopted herein are consistent, in   
  all material respects, with those applied in the most recently published annual 
  financial statements, except as disclosed in note 5, and comply with the        
  requirements of Statements of South African Generally Accepted Accounting       
  Practice.                                                                       
  GROUP BALANCE SHEET                                                             
  Audited             
                                                 Unaudited      As at             
                                            As at 31 March    30 Sept             
                                         2004         2003       2003             
  Rm           Rm         Rm             
  ASSET                                                                           
  Non-current assets                  4,836.3      4,571.4    4,562.9             
  Property, plant & equipment         1,695.8      1,500.8    1,631.4             
  Goodwill and other                    712.0        377.0      454.7             
  intangibles                                                                     
  Investments                         2,256.3      2,480.3    2,282.5             
  Deferred tax asset                    172.2        213.3      194.3             
  Current assets                      7,114.3      6,242.9    6,652.3             
  Inventories                         2,558.1      2,497.1    2,315.0             
  Accounts receivable                 3,516.1      3,109.9    3,312.2             
  Cash and cash equivalents           1,040.1        635.9    1,025.1             
  TOTAL ASSETS                       11,950.6     10,814.3   11,215.2             
  EQUITY AND LIABILITIES                                                          
  Capital and reserves                3,557.8      2,987.3    3,336.8             
  Share capital and premium             749.6        709.7      721.4             
  Non-distributable reserves          2,808.2      2,277.6    2,615.4             
  and accumulated profits                                                         
  Minority interest                     138.2        134.3      132.2             
  Total non-current liabilities       3,218.3      3,085.5    3,004.8             
  Deferred tax liability                450.6        338.8      373.3             
  Provision for post-retirement         419.0        383.7      399.9             
  medical aid                                                                     
  Long-term borrowings                2,348.7      2,363.0    2,231.6             

  Total current liabilities           5,036.3      4,607.2    4,741.4             
  Short-term borrowings                 645.5        533.5      705.1             
  Taxation                              190.6        185.2      350.7             
  Accounts payable                    4,200.2      3,888.5    3,685.6             
  TOTAL EQUITY AND LIABILITIES       11,950.6     10,814.3   11,215.2             
  GROUP INCOME STATEMENT                                                          
                                         Unaudited             Audited            
                                  Six months ended          Year ended            
  31 March             30 Sept            
                      Notes        2004       2003  Change        2003            
                                     Rm         Rm       %          Rm            
  Revenue                      12,719.4   11,346.0      12    23,039.1            
  Continuing                   12,566.7   11,153.9      13    22,708.1            
  operations                                                                      
  Discontinued                    152.7      192.1               331.0            
  operations                                                                      
  Operating income    1         1,130.6      806.6      40     1,918.2            
  before                                                                          
  amortisation of                                                                 
  intangibles                                                                     
  Continuing                    1,129.4      816.8      38     1,935.6            
  operations                                                                      
  Discontinued                      1.2     (10.2)              (17.4)            
  operations                                                                      
  Amortisation of     2            17.9        6.6                20.2            
  intangibles                                                                     
  Operating income              1,112.7      800.0      39     1,898.0            
  after amortisation                                                              
  of intangibles                                                                  
  Income from                      16.8       20.2                48.7            
  investments                                                                     
  Net financing                 (109.1)    (102.5)             (221.4)            
  costs                                                                           
  Profit before                 1,020.4      717.7      42     1,725.3            
  taxation and                                                                    
  abnormal items                                                                  
  Abnormal items      3         (133.9)        2.3                16.1            
  Profit before                   886.5      720.0      23     1,741.4            
  taxation                                                                        
  Income tax expense              333.2      229.7               548.9            
  Net profit after                553.3      490.3      13     1,192.5            
  taxation                                                                        
  Income from         4            11.5       29.3    (61)        92.7            
  associates                                                                      
  Minority interest               (6.9)     (17.6)              (27.3)            
  Dividends on                        -          -               (0.1)            
  preference shares                                                               
  Net profit for the              557.9      502.0      11     1,257.8            
  period                                                                          
  Number of ordinary            168,160    167,169             167,466            
  shares in issue                                                                 
  (000"s)                                                                         
  Weighted average              167,861    167,013             167,106            
  number of ordinary                                                              
  shares on which                                                                 
  headline earnings                                                               
  and basic earnings                                                              
  per share are                                                                   
  based (000"s)                                                                   
  Headline earnings               419.7      327.6      28       777.0            
  per ordinary share                                                              
  (cents)                                                                         
  Diluted headline                416.2      326.1      28       768.4            
  earnings per                                                                    
  ordinary share                                                                  
  (cents)                                                                         
  Basic earnings per              332.4      300.6               752.7            
  ordinary share                                                                  
  (cents)                                                                         
  Diluted basic                   329.6      299.2               744.3            
  earnings per                                                                    
  ordinary share                                                                  
  (cents)                                                                         
  Dividends per                   100.0       79.0      27       290.0            
  ordinary share                                                                  
  (cents)                                                                         
  Interim dividend              100.0       79.0                79.0            
  declared                                                                        
    Final dividend                                               211.0            
  declared                                                                        
  Reconciliation Between Net Profit And Headline Earnings                         
                                             Rm      Rm            Rm             
  Net profit for the period               557.9   502.0       1,257.8             
  Adjusted for:                                                                   
  Losses on sale or discontinuation         9.0       -             -             
  of operations, net                                                              
  (Profit)/loss on sale of fixed         (18.4)     3.8        (17.4)             
  assets, net of impairment charge                                                
  Net loss on sale of interest in             -     2.2          10.5             
  subsidiaries and joint ventures                                                 
  Impairment of investments               140.9       -             -             
  Goodwill amortisation                    13.6     3.7          11.4             
  Associates                                1.5    35.5          37.4             
  Discontinuation of operations             1.2    35.0          35.0             
  Other                                     0.3     0.5           2.4             
  Other                                       -       -         (1.3)             
  Headline earnings for the period        704.5   547.2  29   1,298,4             
  ABRIDGED CASH FLOW STATEMENT                                                    
                                                              Audited             
                                                Unaudited  Year ended             
  Six months ended                         
                                                 31 March     30 Sept             
                                            2004     2003        2003             
                                              Rm       Rm          Rm             
  Cash operating profit                  1,308.4    944.7     2,289.2             
  Working capital changes                  (0.6)  (328.5)     (372.8)             
  Net interest paid                      (109.1)  (102.5)     (221.4)             
  Dividends received                        20.8     32.1        85.5             
  Taxation paid                          (417.4)  (466.3)     (606.9)             
  Cash available from operations           802.1     79.5     1,173.6             
  Dividends paid                         (358.4)  (357.1)     (500.4)             
  Net cash inflow/(outflow) from           443.7  (277.6)       673.2             
  operating activities                                                            
  Net cash outflow from investing        (536.3)  (588.7)   (1,186.9)             
  activities                                                                      
  Net cash outflow before financing       (92.6)  (866.3)     (513.7)             
  activities                                                                      
  Net cash inflow/(outflow) from           123.8  (122.8)      (69.1)             
  financing activities                                                            
  Net increase/(decrease) in cash and       31.2  (989.1)     (582.8)             
  cash equivalents including short                                                
  term borrowings regarded as cash                                                
  and cash equivalents                                                            
  SEGMENTAL ANALYSIS                                                              
  Unaudited    Unaudited                Audited             
                       Six months   Six months             Year ended             
                            ended        ended                                    
                         31 March  31 March **             30 Sept **             
  2004         2003  Change           2003             
                      Rm     %        Rm     %      %        Rm     %             
  Revenue -                                                                       
  continuing                                                                      
  operations                                                                      
  FMCG -         5,025.0    39   4,453.9    40     13   9,276.5    39             
  Domestic                                                                        
  Domestic       4,363.1    34   3,894.5    35     12   8,203.3    35             
  Food                                                                            
  Grains         2,179.4    17   2,378.7    21    (8)   4,740.1    20             
  - Milling      1,674.2    13   1,912.3    17   (12)   3,753.8    16             
  and baking                                                                      
  +                                                                               
  - Other          505.2     4     466.4     4      8     986.3     4             
  grains #                                                                        
  Groceries        752.8     6     643.1     6     17   1,337.4     6             
  Snacks &         457.6     4     443.9     4      3     865.3     4             
  Treats                                                                          
  Perishables      973.3     7     428.8     4    127   1,260.5     5             
  Consumer         661.9     5     559.4     5     18   1,073.2     4             
  Healthcare                                                                      
  OTC              144.0     1     125.0     1     15     271.9     1             
  Medicines                                                                       
  Personal         116.7     1     119.5     1    (2)     242.3     1             
  Babycare         139.2     1     115.9     1     20     226.5     1             
  Homecare         262.0     2     199.0     2     32     332.5     1             
  REGULATED        497.3     4     431.5     4     15     911.3     4             
  HEALTHCARE                                                                      
  Branded          338.3     3     313.9     3      8     639.5     3             
  Medicines                                                                       
  Generic          159.0     1     117.6     1     35     271.8     1             
  Medicines                                                                       
  HOSPITAL         328.9     2     293.3     2     12     617.2     3             
  PRODUCTS                                                                        
  EXPORTS          292.9     2     395.2     3   (26)     621.1     3             
  SPAR           6,073.6    47   5,074.5    43     20  10,121.1    44             
  FISHING          772.5     6     870.3     8   (11)   1,703.9     7             
  OTHER              0.0     0       1.6     0      0       2.5     0             
                12,990.2   100  11,520.3   100     13  23,253.6   100             
  Less:            423.5           366.4                  545.5                   
  Intragroup                                                                      
  revenue                                                                         
                12,566.7        11,153.9           13  22,708.1                   
  Operating                                                                       
  Income -                                                                        
  continuing                                                                      
  operations*                                                                     
  FMCG -           554.1    49     305.7    37     81     886.3    46             
  Domestic                                                                        
  Domestic         421.8    38     199.7    24    111     666.9    34             
  Food                                                                            
  Grains           239.2    21      72.2     9    231     391.3    20             
  - Milling        149.2    13      21.1     3    607     259.6    13             
  and baking                                                                      
  +                                                                               
  - Other           90.0     8      51.1     6     76     131.7     7             
  grains #                                                                        
  Groceries         74.7     7      71.9     9      4     130.7     7             
  Snacks &          17.1     2      44.9     5   (62)      85.4     4             
  Treats                                                                          
  Perishables       90.8     8      10.7     1    749      59.5     3             
  Consumer         132.3    11     106.0    13     25     219.4    12             
  Healthcare                                                                      
  OTC               46.6     4      41.0     5     14      93.8     5             
  Medicines                                                                       
  Personal          23.7     2      23.3     3      2      52.5     3             
  Babycare          23.4     2      14.7     2     59      32.0     2             
  Homecare          38.6     3      27.0     3     43      41.1     2             
  REGULATED        209.7    18     186.0    23     13     389.4    20             
  HEALTHCARE                                                                      
  Branded          161.4    14     153.9    19      5     315.8    16             
  Medicines                                                                       
  Generic           48.3     4      32.1     4     50      73.6     4             
  Medicines                                                                       
  HOSPITAL          96.4     9      80.7    10     19     175.5     9             
  PRODUCTS                                                                        
  EXPORTS         (18.4)   (2)    (38.7)   (5)     52    (78.2)   (4)             
  SPAR             215.5    20     178.1    22     21     346.4    18             
  FISHING           80.5     7     118.2    14   (32)     219.1    11             
  OTHER            (8.4)   (1)    (13.2)   (1)     36     (2.9)   (0)             
  1,129.4   100     816.8   100     38   1,935.6   100             
  +    Comprised Maize milling, Wheat milling and baking, sorghum beverages and   
       malt based breakfast cereals                                               
  #    Comprises Rice and oat based breakfast cereals                             
  *    Operating Income is stated before amortisation of intangible assets        
  **   Reallocation between certain segments                                      
  OTHER GROUP SALIENT FEATURES                                                    
                                                   Unaudited   Audited            
  Six months      Year            
                                                       ended     ended            
                                                    31 March   30 Sept            
                                              2004     2003      2003             
  Net worth per ordinary share (cents)       2,120    1,787     1,993             
  Net debt to equity (%)                      52.9     72.4      55.1             
  Interest cover - net (times)                10.4      8.0       8.8             
  Current ratio (:1)                           1.4      1.4       1.4             
  Capital expenditure (R million)            206.9    162.3     359.5             
  - expansion                                128.0     81.2     164.7             
  - replacement                               78.9     81.1     194.8             
  Capital commitments (R million)            101.5     82.7     232.8             
  - contracted                                53.5     33.5     102.5             
  - approved                                  48.0     49.2     130.3             
  Capital commitments will be funded                                              
  from normal operating cash flows and                                            
  the utilisation of existing borrowing                                           
  facilities                                                                      
  Contingent liabilities (R million)                                              
  Guarantees and contingent                  813.9    605.9     734.2             
  liabilities *                                                                   
  * R559.2 million (Sep 2003: R479.5                                              
  million) comprises contingencies in                                             
  respect of head leases entered into                                             
  by the Spar group for which they have                                           
  entered into equivalent sub-leases.                                             
  Carrying value of investments            2,256.3  2,480.3   2,282.5             
  (R million)                                                                     
  Listed                                     374.8    232.8     291.5             
  Unlisted                                 1,276.4  1,184.2   1,222.2             
  Associates                                 605.1  1,063.3     768.8             
  Fair valuation of investments            2,263.3  2,480.3   2,283.8             
  (R million)                                                                     
  Listed - market value                      374.8    232.8     291.5             
  Unlisted - directors" valuation          1,276.4  1,184.2   1,222.2             
  Associates - directors" valuation          612.1  1,063.3     770.1             
  NOTES                                                                           
                                                  Unaudited    Audited            
                                                 Six months       Year            
                                                      ended      ended            
  31 March    30 Sept            
                                             2004     2003       2003             
                                               Rm       Rm         Rm             
  1. Operating income                                                             
  Operating income before amortisation                                            
  of intangibles is reflected after                                               
  charging:                                                                       
  Cost of sales                           9,609.6  8,750.7   17,507.1             
  Sales and distribution expenses         1,038.2    918.9    1,875.2             
  Marketing expenses                        268.8    259.9      555.6             
  Other operating expenses                  672.2    609.9    1,183.0             
  Depreciation (included in cost of         125.3    128.7      259.8             
  sales and other operating expenses)                                             
  2. Amortisation of intangibles                                                  
  Goodwill                                   13.6      3.7       11.4             
  Trademarks and other intangible             4.3      2.9        8.8             
  assets                                                                          
                                             17.9      6.6       20.2             
  3. Abnormal Items                                                               
  Net loss on discontinuation of           (11.7)        -          -             
  operations                                                                      
  Profit on sale of land and buildings       24.8      4.5       26.6             
  net of impairment charge on                                                     
  properties                                                                      
  Net loss on sale of interest in               -    (2.2)     (10.5)             
  subsidiaries and joint ventures                                                 
  Impairment of investments               (142.2)        -          -             
  Other                                     (4.8)        -          -             
  Abnormal (loss)/profit before           (133.9)      2.3       16.1             
  taxation                                                                        
  Taxation                                    2.6    (0.9)        1.4             
                                          (131.3)      1.4       17.5             
  Outside shareholders" interest            (2.2)      1.5      (0.2)             
  Abnormal (loss)/profit attributable     (133.5)      2.9       17.3             
  to shareholders in Tiger Brands                                                 
  Limited                                                                         
  4. Income from associates                                                       
  Normal trading                             12.7     64.3      129.2             
  Abnormal items                            (1.2)  (35.0)*     (36.5)             
  Discontinuation of operations             (1.2)   (35.0)     (35.0)             
  Other                                         -        -      (1.5)             
                                             11.5     29.3       92.7             
  *    Previously disclosed under Abnormal Items.                                 
  5.   Change In Accounting Policy                                                
  In terms of the JSE Listings Requirements, the Tiger Brands Share Purchase 
       Trust is now consolidated. The Trust does not hold any shares in Tiger     
       Brands Limited but holds a number of shares in Astral Foods Limited, which 
       were transferred to the Trust at the time of the unbundling of Astral Foods
  in 2001 to meet the requirements of the Tiger Brands (1985) Share Option   
       Scheme. This change in accounting policy has not had an effect on earnings 
       in the current reporting period or in the prior year. The balance sheets as
       at 31 March 2003 and 30 September 2003 have been restated to reflect the   
  shares in Astral Foods at their market value as well as the fair value of  
       the liability on respect of the Astral options granted.                    
  STATEMENT OF CHANGES IN EQUITY                                                  
                         Share            Non-                                    
  capital and   distributable  Accumulated                       
                       premium        reserves      profits     Total             
                            Rm              Rm           Rm        Rm             
  Balance at 30          721.4           378.7      2,236.7   3,336.8             
  September 2003                                                                  
  Issue of share          28.2                                   28.2             
  capital and                                                                     
  premium                                                                         
  Fair value                              44.1                   44.1             
  adjustments -                                                                   
  investments                                                                     
  Foreign                               (20.7)                 (20.7)             
  currency                                                                        
  translation                                                                     
  reserve                                                                         
  movement                                                                        
  Transfers                               14.4       (14.4)       0.0             
  between                                                                         
  reserves                                                                        
  Movements in                          (34.0)                 (34.0)             
  reserves of                                                                     
  associates                                                                      
  Net profit for                                      557.9     557.9             
  the period                                                                      
  Dividends on                                      (354.5)   (354.5)             
  ordinary                                                                        
  shares                                                                          
  Balance at 31          749.6           382.5      2,425.7   3,557.8             
  March 2004                                                                      
  Balance at 30         696.4           556.2       1,476.2  2,728.8              
  September 2002                                                                  
  Adjustment to                         290.3           0.9    291.2              
  opening                                                                         
  reserves in                                                                     
  terms of AC133                                                                  
  Adjustment            696.4           846.5       1,477.1  3,020.0              
  balance at 1                                                                    
  October 2002                                                                    
  Issue of share         13.3                                   13.3              
  capital and                                                                     
  premium                                                                         
  Fair value                           (55.6)                 (55.6)              
  adjustment -                                                                    
  investments                                                                     
  Foreign                             (200.1)                (200.1)              
  currency                                                                        
  translation                                                                     
  reserve                                                                         
  movement                                                                        
  Transfers                              21.9        (21.9)      0.0              
  between                                                                         
  reserves                                                                        
  Movements in                           60.4                   60.4              
  reserves of                                                                     
  associates                                                                      
  Net profit for                                      502.0    502.0              
  the period                                                                      
  Dividends on                                      (352.7)  (352.7)              
  ordinary                                                                        
  shares                                                                          
  Balance at 31         709.7           673.1       1,604.5  2,987.3              
  March 2003                                                                      
  REVIEW OF OPERATIONS                                                            
  Tiger Brands achieved an increase of 28% in headline earnings per share for the 
  six months ended 31 March 2004 compared to the corresponding period last year.  
  This result has been influenced by a strong performance from the company"s local
  FMCG (fast moving consumer goods) businesses, including a significant           
  improvement in the contribution to operating income by the Grains businesses.   
  During the reporting period, the acquisition of Nelspruit Wholesalers (Pty) Ltd 
  by The Spar Group Limited was finalised and these results have been consolidated
  from 1 November 2003, the date of acquisition.                                  
  RESULTS                                                                         
  Revenue from continuing operations rose by 13% with operating income reflecting 
  a 38% improvement. The operating margin increased to 9.0% (2003: 7.3%). Whereas 
  the past two years" results have been significantly affected by the volatility  
  of the Rand, the period under review has been characterised by a more stable    
  currency.  The strength of the Rand over the reporting period has, however,     
  again impacted upon the Company"s exports which continued to show a loss, albeit
  at a lower level compared to the previous year.                                 
  Acquisitions during the course of 2003, together with the acquisition of        
  Nelspruit Wholesalers during the current reporting period, have had a           
  significant effect on revenue and operating income comparisons relative to the  
  previous year. Comparisons are also affected by the consolidation of Enterprise 
  Foods (Pty) Limited as a wholly-owned subsidiary with effect from 1 May 2003,   
  following last year"s acquisition by Tiger Brands of the remaining 50% interest 
  in that company. The results of Enterprise Foods were previously equity         
  accounted. On a strictly comparable basis, excluding the effect of acquisitions,
  revenue and operating income increased by 3% and 22% respectively.              
  The income statement reflects a net abnormal charge of R133.9 million in the    
  current reporting period. This includes an impairment provision of R137.2       
  million taken against the carrying value of the company"s investment in         
  associate company C & T Malt. This write-down was necessitated by the continuing
  deterioration in profitability which has been experienced by the US, Canadian   
  and UK operations of C & T Malt.                                                
  The results for the period were underpinned by a strong cash flow performance.  
  Before investment and financing activities, there was a net cash inflow of      
  R443.7 million compared to a net cash outflow of R277.6 million last year. This 
  improvement of R721.3 million was largely attributable to an increase in cash   
  operating profit of R363.7 million and the containment of working capital levels
  in line with those reported at 30 September 2003. In the prior year, an amount  
  of R372.8 million was utilised to fund increased working capital requirements.  
  Notwithstanding the cost of recent acquisitions, which has absorbed some R526   
  million of cash in the last 12 months, net financing costs were at a similar    
  level to last year, resulting in a further improvement in the interest cover    
  ratio to 10.4 times (2003: 8.0). The balance sheet at 31 March 2004 reflected   
  net borrowings of R1 954.1 million compared to net borrowings of R2 260.6       
  million a year ago, with a corresponding reduction in net gearing to 53% (2003: 
  72%).                                                                           
  Income from associates reduced by 61% to R11.5 million (2003: R29.3 million).   
  However, the figures are not directly comparable as a result of the inclusion of
  an abnormal charge of R35.0 million in the previous year (C&T Malt plant closure
  costs) as well as the equity accounted earnings of Enterprise Foods. On a like  
  for like basis, the most significant change relates to the earnings of C & T    
  Malt, where there was a positive profit contribution of R30.5 million in 2003   
  compared to a small loss incurred in the current period. This reversal in       
  profitability is a reflection of the extremely difficult trading conditions     
  being encountered by the malt industry worldwide. Empresas Carozzi performed    
  ahead of expectations, although the appreciation of the Chilean peso against    
  most South and Central American currencies continued to have an adverse effect  
  on Carozzi"s export earnings. On an after tax basis, its contribution to Tiger"s
  earnings was below the previous year as a result of Carozzi now being in a full 
  tax paying position following the utilisation, last year, of all remaining tax  
  losses.                                                                         
  FMCG - Domestic                                                                 
  The FMCG - Domestic operations performed well, reflecting an 81% increase in    
  operating income compared to the previous year on a 13% revenue increase.       
  The results of the Domestic Food operations were bolstered by a significant     
  improvement in the Grains business. This improvement was assisted by a sharp    
  turnaround in the Maize milling operations which returned to profitability after
  incurring a loss of R78.8 million in the previous year. This loss included the  
  write-off of R73 million in respect of maize hedging costs, necessitated by the 
  sharply falling maize price over that period.  The Domestic Food results were   
  further enhanced by the inclusion of Value-Added Meat Products (Enterprise)     
  within Perishables.                                                             
  An 8% decline in revenue in the Grains category was primarily attributable to a 
  reduction in maize volumes as a consequence of aggressive competitor pricing    
  activity, together with price deflation in the maize market. The Maize milling  
  business is currently operating profitably, despite the volume decline. In      
  addition, steps have been taken to reduce the cyclicality of the business. The  
  Wheat milling business recorded steady growth in operating income, benefiting   
  from relatively stable raw material pricing.                                    
  Bakeries (Albany) performed well, significantly improving their performance     
  compared to the previous year. The launch of a new Superior bread (Best of Both)
  in April 2004 and ongoing investment in product quality and technology upgrades,
  should see the current momentum carried through to the second half.             
  King Food enjoyed increased levels of profitability driven by recoveries in the 
  sorghum malt and beer powder markets and volume growth in the Morvite breakfast 
  cereal range.                                                                   
  Rice recorded a strong increase in operating income largely as a result of good 
  volume growth in the premium brands (Tastic and Aunt Caroline) and the benefits 
  of low raw material input costs as a result of the strengthening Rand. Jungle   
  Oats benefited from lower raw material procurement costs, which led to increased
  levels of profitability. The launch of the muesli breakfast product, Jungle     
  Energy Crunch, has been a significant contributor to the growth of the brand.   
  The Groceries segment includes Condiments & Ingredients (All Gold, Colmans),    
  Spreads (All Gold, Black Cat), Pasta (Fatti"s & Moni"s) and Desserts &          
  Vegetables (Koo). This segment reflected a 4% increase in operating income on a 
  17% growth in revenue.                                                          
  The domestic grocery business has benefited from strong volume growth in the key
  areas of tomato sauce and baked beans, and also from tight control of costs.    
  Innovations in peanut butter and soups will be launched in the second half of   
  the year. The Pasta business has been adversely affected by increased           
  competition from imported pasta and dealer own brands. A better performance is  
  expected in the second half.                                                    
  The Snacks & Treats business (Beacon) recorded a 62% decline in operating income
  on a 3% increase in revenue. These results reflect the extremely difficult      
  trading environment in the local sugar confectionery market where aggressive    
  competition from South America has seen the company"s volumes running well      
  behind the prior year. The situation has been exacerbated by the impact on      
  production levels of high stock levels at the beginning of the year, which has  
  had an adverse effect on labour and factory overhead recoveries. Retrenchment   
  costs of R13.8 million were also provided for in the period under review. A     
  significantly improved performance is expected in the second-half of the year.  
  The Perishables category comprises Value-Added Meat Products (Enterprise) and   
  the Dairy business (DairyBelle). Value-Added Meat Products produced a strong    
  performance, confirming the value of this operation as a wholly-owned           
  subsidiary. The business benefited from raw material cost reductions arising    
  from the stronger Rand and also from favourable production yields. Some volume  
  growth was recorded in viennas and polonies. Although DairyBelle"s overall      
  performance was pleasing, the cheese results for the half year were affected by 
  adverse market conditions, primarily in the bulk cheese sector. Overall, the    
  Dairy business is benefiting from a drive to revitalise the DairyBelle brand.   
  The Consumer Healthcare operations improved operating income by 25% on an 18%   
  revenue increase.                                                               
  OTC Medicines (schedule O and 1 medicines) showed a satisfactory growth in      
  revenue and operating income, benefiting from a good performance in the second  
  quarter. Panado recorded volume growth notwithstanding increased competition    
  from housebrands. There was a strong performance from Compral, whilst the       
  benefits of innovation have seen revenue double in the Bioplus brand.           
  Personal Care reflected a marginal increase in operating income, with the       
  performance of the bodycare category being particularly disappointing. Ingram"s 
  Camphor Cream experienced pressure on sales volumes as did Gill shampoo. The    
  Facecare business achieved a good result, influenced by a strong performance    
  from Lemon Lite.                                                                
  The Babycare category performed well, with both Purity and Elizabeth Anne"s     
  recording good revenue growth. Purity"s Cream of Maize Meal brand has been      
  particularly successful. The Homecare category benefited from strong sales of   
  insecticide (Doom, Fastkill, the Dy-range), and the relaunch of the Jeyes and   
  Airoma brands during the period.                                                
  REGULATED HEALTHCARE                                                            
  Regulated Healthcare, which comprises Branded Prescription Medicines (including 
  Schedule 2 drugs) and Generic Medicines, reflected a 13% increase in operating  
  income on a 15% revenue growth. These results were achieved during a period of  
  uncertainty following the publication of the Draft Drug Pricing Regulations in  
  January 2004. Branded Prescription Medicines produced a satisfactory performance
  notwithstanding continued downward pressure on medicine prices as a result of   
  steps taken by Government and healthcare funders to reduce the cost of medicine.
  These margin pressures were to some extent ameliorated by the impact of the     
  strengthening Rand over the period which reduced raw material input costs.      
  Declining sales volumes continued to be experienced in the Lentogesic and Syndol
  brands, whilst Corenza C, Mypaid, Medi-Keel and Pynstop recorded good volume    
  growth. The integration of the Parke-Med business, which was acquired towards   
  the end of the last financial year, was successfully completed.                 
  The Generic Medicines business achieved an excellent performance, increasing    
  revenue and operating income by 35% and 50% respectively. These results         
  benefited from a generic market which is showing strong growth and also from the
  success of new products including Adco-Simvastatin and Adco-Zolpidem.  There is 
  an extensive list of new products, covering both acute and chronic medicines,   
  currently in the registration process.                                          
  The recent publication of the regulations relating to drug pricing in terms of  
  the Medicines and Related Substances Control Act, whilst not to the satisfaction
  of all industry participants, reflects the outcome of a positive engagement     
  between the Department of Health and industry representatives.                  
  HOSPITAL PRODUCTS                                                               
  Hospital Products showed an increase of 19% in operating income on an increase  
  in revenue of 12%. Profitability was favourably influenced by the ongoing       
  introduction of new products, particularly in the areas of wound care management
  and intravenous infusion systems, and the impact of the strong Rand on imported 
  costs. Good performances were recorded by Renal Products, Blood Products and    
  Hospital Pharmaceuticals.                                                       
  EXPORTS                                                                         
  The Export operations incurred a reduced loss of R18.4 million (2003: R38.7     
  million). Exports primarily consist of canned deciduous fruit where, despite    
  improvements in both sales volumes and dollar prices, the impact of the stronger
  Rand resulted in a loss for the period. Currency losses on the conversion of    
  foreign monetary assets accounted for approximately R13 million of the overall  
  loss. The outlook is encouraging for a return to profitability in the second six
  months.                                                                         
  SPAR                                                                            
  Spar achieved satisfactory results, increasing revenue and operating income by  
  20% and 21% respectively. The results of Nelspruit Wholesalers (Pty) Limited    
  were incorporated with effect from 1 November 2003. Excluding the results of    
  Nelspruit Wholesalers, revenue and operating income increased by 12% and 13%    
  respectively.                                                                   
  In an extremely competitive environment, with sustained low levels of inflation,
  operating margins have held up well. Spar continues to focus on its perishables 
  business which recorded a 15% growth in revenue.                                
  During the period, 17 new Spar stores were opened whilst a further 38 stores    
  were upgraded. There are now a total number of 762 voluntary traded retail      
  stores in South Africa, inclusive of the Nelspruit Wholesalers" stores.         
  SPAR UNBUNDLING                                                                 
  The board of Tiger Brands Limited has been considering a number of strategic    
  alternatives with regard to the optimal future structure of the group in order  
  to maximize shareholder value. To this end it is intended to unbundle the Spar  
  business and to list it as a separate entity on the JSE Securities Exchange     
  South Africa before the end of 2004. Any such unbundling and subsequent listing 
  of Spar would be subject to all appropriate regulatory requirements, the        
  provision of further details to shareholders relating to the proposed           
  transaction and the ultimate approval of shareholders.                          
  FISHING                                                                         
  The Company"s Fishing interests, which comprise 73% held Sea Harvest and 41%    
  held Oceana, reflected a 32% decline in operating income on an 11% fall in      
  revenue. The Company"s investment in Oceana is proportionately consolidated.    
  Despite volume growth, margins at Sea Harvest were negatively impacted by the   
  effect of the stronger Rand on export realisations, a higher percentage of low  
  value, small fish, compared to the previous year and higher catch costs as a    
  result of the relocation of fishing vessels from the West Coast to the East     
  Coast where catching conditions were more favourable.                           
  Separately listed Oceana experienced a 15% decrease in headline earnings per    
  share. Pilchard landings were higher than those for the same period last year,  
  however, production yields were lower due to poor fish size and the increased   
  distance to fishing grounds. Although lobster catches were good, export         
  realisations were lower due to both weaker dollar selling prices and the        
  stronger Rand. The strong Rand also affected the turnover of the Midwater       
  pelagic fishing operations. The Squid operations performed well, with record    
  catches for the second successive year. The trading results of Glenryk (UK)     
  Limited, which was acquired for R73 million, will be consolidated from 1 April  
  2004.                                                                           
  DIVESTMENT                                                                      
  The Company recently obtained the approval of the Competition Commission for the
  disposal of its edible oils & margarine business to a local manufacturer. The   
  effective date of the disposal is 31 May 2004. The effect of the disposal on    
  Tiger"s earnings and net asset value per share is not material.                 
  DIVIDEND POLICY, INTERIM DIVIDEND AND SHARE REPURCHASE                          
  In view of the Company"s strong cash generating capability, a decision has been 
  taken by the board to return to shareholders an increasing percentage of profits
  in the form of higher cash dividends. The board has decided to adopt a          
  progressive dividend policy in terms of which it is anticipated that the annual 
  dividend cover will be reduced over time.                                       
  In line with this policy, it has been decided to reduce the annual dividend     
  cover for 2004 to 2.5 times and to also partially address the historic imbalance
  between the interim and final dividend relative to headline earnings per share. 
  Taking these factors into account, together with the prospects for the remainder
  of the year, the Company has declared an interim dividend of 100 cents per share
  for the half-year ended 31 March 2004. This represents an increase of 27% on    
  last year"s interim dividend of 79 cents per share.                             
  In addition, the board has resolved to execute the mandate provided by          
  shareholders at the February 2004 AGM to repurchase the company"s shares as part
  of a general share buyback programme. Such repurchases will take place subject  
  to prevailing market conditions and the company"s future cash flow requirements.
  It is anticipated that this measure should improve returns to shareholders over 
  time.                                                                           
  PROSPECTS                                                                       
  Although the Company has produced a pleasing set of results for the period under
  review, comparisons against last year are affected by a number of factors which 
  significantly depressed the results for the six month period ended 31 March     
  2003. These factors included the impact on margins of the sharply falling maize 
  price, the effect of the utilisation of higher priced maize stocks carried over 
  from 2002, maize hedging costs written off and the impact of the strengthening  
  Rand.                                                                           
  The trading outlook for the second six months of the current financial year     
  ending 30 September 2004 is positive, although the effects of competitive       
  pressures in a low inflationary environment will continue to be felt. Overall,  
  headline earnings for the full year will show a rate of increase well below that
  reported at the half year. Nevertheless, headline earnings are still expected to
  reflect real growth compared to the previous year.                              
  For and on behalf of the Board:                                                 
  R A WILLIAMS                                                                    
  Chairman                                                                        
  N DENNIS                                                                        
  Chief Executive Officer                                                         
  13 May 2004                                                                     
  DECLARATION OF ORDINARY DIVIDEND NO 119                                         
  Notice is hereby given that an interim dividend of 100 cents per ordinary share 
  has been declared in respect of the half-year ended, 31 March 2004.             
  In compliance with the requirements of STRATE, the electronic settlement and    
  custody system used by the JSE Securities Exchange South Africa, the company has
  determined the following salient dates for the payment of the dividend:         
  Last day to trade cum-dividend          Friday, 2 July 2004                     
  Shares commence trading ex-dividend     Monday, 5 July 2004                     
  Record date                             Friday, 9 July 2004                     
  Payment of dividend                    Monday, 12 July 2004                     
  Shareholders will not be permitted to dematerialise/rematerialise their shares  
  between Monday, 5 July 2004 and Friday, 9 July 2004, both days inclusive.       
  By order of the board                                                           
  I W M Isdale                 Sandton                                            
  Secretary                    13 May 2004                                        
  Directors:                                                                      
  Independent directors:                                                          
  R A Williams (Chairman), B H Adams, D D B Band, B P Connellan, U P T Johnson,   
  A C Nissen, G N Padayachee, B L Sibiya, J L van den Berg, L C van Vught        
  Executive:                                                                      
  N Dennis (Chief Executive Officer) (British), M H Franklin, J H McBain          
  (British), M C Norris, R V Smither, C F H Vaux                                  
  Company secretary:                                                              
  I W M Isdale                                                                    
  Share registrars:                                                               
  Computershare Limited,                                                          
  Investor Services Division                                                      
  PO Box 61051,                                                                   
  Marshalltown, 2107,                                                             
  South Africa                                                                    
  70 Marshall Street,                                                             
  Johannesburg, 2001,                                                             
  South Africa                                                                    
  Registered office:                                                              
  85 Bute Lane,                                                                   
  Sandown,                                                                        
  Sandton,                                                                        
  South Africa                                                                    
  PO Box 78056,                                                                   
  Sandton, 2146,                                                                  
  South Africa                                                                    
  These results and a copy of the presentation given to analysts and investors in 
  respect of these results will be available on the company"s web site.           
  WEBSITE ADDRESS: http://www.tigerbrands.com                                     
  Date: 13/05/2004 04:53:40 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: